ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 164 filers reported holding ACCELERON PHARMA INC in Q4 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $928,000 | +472.8% | 5,391 | +217.9% | 0.02% | +155.6% |
| Q2 2020 | $162,000 | +1925.0% | 1,696 | +987.2% | 0.01% | – |
| Q4 2019 | $8,000 | +300.0% | 156 | +164.4% | 0.00% | – |
| Q3 2019 | $2,000 | -33.3% | 59 | -3.3% | 0.00% | – |
| Q2 2019 | $3,000 | -97.9% | 61 | -98.0% | 0.00% | -100.0% |
| Q1 2019 | $145,000 | -88.6% | 3,109 | -86.0% | 0.01% | -89.2% |
| Q3 2018 | $1,274,000 | +129.5% | 22,263 | +94.7% | 0.07% | +111.4% |
| Q2 2018 | $555,000 | +2821.1% | 11,437 | +2187.4% | 0.04% | +1066.7% |
| Q1 2015 | $19,000 | -44.1% | 500 | -50.0% | 0.00% | -25.0% |
| Q2 2014 | $34,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |